They evaluated the IHC Sec62 staining intensity in tissue samples from 53 patients using an IRS cut-off of 8 and determined that OS was worse in patients with SEC62 overexpression, independent of the breast cancer type [19]. This evidence concerns the gene SEC62 and breast cancer.